iPROMOMED
MMOEX:PRMD408.90
RUB
+2.70
(+0.66%)
ISIN
RU000A108JF7
Return %
Stock
S&P 500
1Y
10.39
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Nimesh Shah
- Full Time Employees
- 2,000
- Address
- IPO Date
- Jul 12, 2024
- Website
- promomed.pro
- Similar Companies
- Business
- PROMOMED PJSC operates as a biopharmaceutical and medical technology company focused on developing, manufacturing, and marketing pharmaceutical products and related medical devices within Russia and targeted international markets. The company engages in the full lifecycle of drug development and commercialization, including research and development, manufacturing, regulatory compliance, distribution, and after-sales support for healthcare providers and large corporate clients. Main Products and Services: - Core pharmaceutical products: therapeutic drugs across multiple classes (including oncology, immunology, infectious disease, and supportive care) produced under strict quality controls and regulatory compliance frameworks. - Injectable and oral medications: commercially marketed formulations designed for hospital and ambulatory settings, with emphasis on stable supply chains and patient access programs. - Medical devices and consumables: electrosurgical instruments, endoscopy and minimally invasive surgical devices, disposables, cables and accessories, surgical tools, and related consumables used in clinical procedures. - Diagnostic and laboratory products: diagnostic reagents, assay kits, and ancillary equipment used in clinical laboratories to support patient testing and monitoring. - Contract manufacturing and private-label services: manufacturing capacity for third-party brands, including formulation development, fill–finish, packaging, and regulatory support to enable client product launches. - Regulatory and distribution services: local regulatory counsel, quality assurance, warehousing, and distribution logistics to healthcare institutions, clinics, and distributors. Latest Major Company Changes: - Partnerships and strategic alliances: enters cooperative ventures with domestic pharmaceutical distributors and healthcare providers to expand market access and enhance supply reliability; engages in collaborative programs to accelerate clinical development and regulatory approvals for key product candidates. - Funding rounds and acquisitions: participates in capital raising and corporate transactions to expand manufacturing capacity and R&D capabilities; engages in targeted acquisitions to broaden product portfolio and geographic reach. - Product launches and service expansions: announces new drug formulations, combination therapies, and upgraded medical devices; expands private-label manufacturing for regional partners to diversify revenue streams. - Strategic shifts and expansions: intensifies focus on high-demand therapeutic areas and high-value medical devices, expanding manufacturing footprint and distribution networks to support growth in Russia and select neighboring markets. - Corporate reorganizations: realigns organizational structure to enhance R&D throughput, manufacturing efficiency, and commercial execution; introduces new governance and compliance frameworks to support expanded international operations. - Operational changes: upgrades GMP-compliant facilities, implements advanced quality management systems, and enhances cold-chain and warehouse capabilities to support broader product portfolios and international distribution. Additional Context: - Industry and segments: pharmaceuticals, biotechnology, medical devices, contract development and manufacturing organization (CDMO) services, clinical diagnostics. - Target markets: hospitals, clinics, speciality treatment centers, pharmaceutical distributors, and corporate healthcare buyers in Russia and selected international markets. - Geographic operations: headquartered in Moscow, Russia, with manufacturing and distribution capabilities primarily in Russia and regional export activities to nearby markets; ongoing efforts to broaden international reach. - Founding year and headquarters: established in the early 21st century; headquarters located in Moscow, Russia. - Subsidiaries and parent relationships: operates under a corporate group structure with subsidiaries handling manufacturing, distribution, and regulatory affairs; maintains parent company oversight for strategic direction and capital allocation.